Log In
BCIQ
Print this Print this
 

CNS ProteoCarta proteomic panel

  Manage Alerts
Collapse Summary General Information
Company Caprion Proteomics Inc.
DescriptionSingle, multiplexed multiple reaction monitoring (MRM) assay that allows for the simultaneous detection and quantification of 142 proteins in 75 uL of human cerebrospinal fluid (CSF)
Molecular Target
Mechanism of Action 
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationNeurology, Diagnostic
Indication DetailsDetect and quantify proteins associated with CNS diseases
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today